|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zeng M, Zhu L, Li L and Kang C: miR-378
suppresses the proliferation, migration and invasion of colon
cancer cells by inhibiting SDAD1. Cell Mol Biol Lett. 22:122017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang B, Liu G, Ding L, Zhao J and Lu Y:
FOXA2 promotes the proliferation, migration and invasion, and
epithelial mesenchymal transition in colon cancer. Exp Ther Med.
16:133–140. 2018.PubMed/NCBI
|
|
4
|
Rupaimoole R, Calin GA, Lopez-Berestein G
and Sood AK: miRNA deregulation in cancer cells and the tumor
microenvironment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma W, Liu B, Li J, Jiang J, Zhou R, Huang
L, Li X, He X and Zhou Q: MicroRNA-302c represses
epithelial-mesenchymal transition and metastasis by targeting
transcription factor AP-4 in colorectal cancer. Biomed
Pharmacother. 105:670–676. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dou C, Liu Z, Xu M, Jia Y, Wang Y, Li Q,
Yang W, Zheng X, Tu K and Liu Q: miR-187-3p inhibits the metastasis
and epithelial-mesenchymal transition of hepatocellular carcinoma
by targeting S100A4. Cancer Lett. 381:380–390. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tu K, Liu Z, Yao B, Han S and Yang W:
MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT
signaling in hepatocellular carcinoma. Int J Oncol. 48:965–974.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yin K, Yin W, Wang Y, Zhou L, Liu Y, Yang
G, Wang J and Lu J: MiR-206 suppresses epithelial mesenchymal
transition by targeting TGF-β signaling in estrogen receptor
positive breast cancer cells. Oncotarget. 7:24537–24548. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu X, Zhu Y, Liang Z, Li S, Xu X, Wang X,
Wu J, Hu Z, Meng S, Liu B, et al: c-Met and CREB1 are involved in
miR-433-mediated inhibition of the epithelial-mesenchymal
transition in bladder cancer by regulating Akt/GSK-3beta/Snail
signaling. Cell Death Dis. 7:e20882016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen QY, Jiao DM, Yan L, Wu YQ, Hu HZ,
Song J, Yan J, Wu LJ, Xu LQ and Shi JG: Comprehensive gene and
microRNA expression profiling reveals miR-206 inhibits MET in lung
cancer metastasis. Mol Biosyst. 11:2290–2302. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer. 96
Suppl:R40–R44. 2007.PubMed/NCBI
|
|
12
|
Ma G, Wang Y, Li Y, Cui L, Zhao Y, Zhao B
and Li K: MiR-206, a key modulator of skeletal muscle development
and disease. Int J Biol Sci. 11:345–352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu H, He G and Wang Y, Hu Y, Zhang Z,
Qian X and Wang Y: Long intergenic noncoding RNA 00707 promotes
colorectal cancer cell proliferation and metastasis by sponging
miR-206. Onco Targets Ther. 12:4331–4340. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng X, Ma YF, Zhang XR, Li Y, Zhao HH
and Han SG: Circ_0056618 promoted cell proliferation, migration and
angiogenesis through sponging with miR-206 and upregulating CXCR4
and VEGF-A in colorectal cancer. Eur Rev Med Pharmacol Sci.
24:4190–4202. 2020.PubMed/NCBI
|
|
15
|
Wang Y, Xu H, Si L, Li Q, Zhu X, Yu T and
Gang X: MiR-206 inhibits proliferation and migration of prostate
cancer cells by targeting CXCL11. Prostate. 78:479–490. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang N, Wang L, Liu J, Liu L, Huang J,
Chen X and Luo Z: MicroRNA-206 regulates the epithelial-mesenchymal
transition and inhibits the invasion and metastasis of prostate
cancer cells by targeting Annexin A2. Oncol Lett. 15:8295–8302.
2018.PubMed/NCBI
|
|
17
|
Liao M and Peng L: MiR-206 may suppress
non-small lung cancer metastasis by targeting CORO1C. Cell Mol Biol
Lett. 25:222020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan C, Liu N, Zheng D, Du J and Wang K:
MicroRNA-206 inhibits metastasis of triple-negative breast cancer
by targeting transmembrane 4 L6 family member 1. Cancer Manag Res.
11:6755–6764. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fu Y, Shao ZM, He QZ, Jiang BQ, Wu Y and
Zhuang ZG: Hsa-miR-206 represses the proliferation and invasion of
breast cancer cells by targeting Cx43. Eur Rev Med Pharmacol Sci.
19:2091–2104. 2015.PubMed/NCBI
|
|
20
|
Shengnan J, Dafei X, Hua J, Sunfu F,
Xiaowei W and Liang X: Long non-coding RNA HOTAIR as a competitive
endogenous RNA to sponge miR-206 to promote colorectal cancer
progression by activating CCL2. J Cancer. 11:4431–4441. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pan JY, Sun CC, Bi ZY, Chen ZL, Li SJ, Li
QQ, Wang YX, Bi YY and Li DJ: miR-206/133b cluster: A weapon
against lung cancer? Mol Ther Nucleic Acids. 8:442–449. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang XW, Xi XQ, Wu J, Wan YY, Hui HX and
Cao XF: MicroRNA-206 attenuates tumor proliferation and migration
involving the downregulation of NOTCH3 in colorectal cancer. Oncol
Rep. 33:1402–1410. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Zheng W, Zhang X, Dong M and Sun G:
The diagnostic and prognostic value of serum miR-206 in colorectal
cancer. Int J Clin Exp Pathol. 10:7528–7533. 2017.PubMed/NCBI
|
|
26
|
Sun P, Sun D, Wang X, Liu T, Ma Z and Duan
L: miR-206 is an independent prognostic factor and inhibits tumor
invasion and migration in colorectal cancer. Cancer Biomark.
15:391–396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Park YR, Seo SY, Kim SL, Zhu SM, Chun S,
Oh JM, Lee MR, Kim SH, Kim IH, Lee SO, et al: MiRNA-206 suppresses
PGE2-induced colorectal cancer cell proliferation, migration, and
invasion by targetting TM4SF1. Biosci Rep. 38:BSR201806642018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meng X and Fu R: miR-206 regulates 5-FU
resistance by targeting Bcl-2 in colon cancer cells. Onco Targets
Ther. 11:1757–1765. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ren XL, He GY, Li XM, Men H, Yi LZ, Lu GF,
Xin SN, Wu PX, Li YL, Liao WT, et al: MicroRNA-206 functions as a
tumor suppressor in colorectal cancer by targeting FMNL2. J Cancer
Res Clin Oncol. 142:581–592. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dai C, Xie Y, Zhuang X and Yuan Z: MiR-206
inhibits epithelial ovarian cancer cells growth and invasion via
blocking c-Met/AKT/mTOR signaling pathway. Biomed Pharmacother.
104:763–770. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mataki H, Seki N, Chiyomaru T, Enokida H,
Goto Y, Kumamoto T, Machida K, Mizuno K, Nakagawa M and Inoue H:
Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR
oncogenic signaling in lung squamous cell carcinoma. Int J Oncol.
46:1039–1050. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen X, Tong ZK and Zhou JY, Yao YK, Zhang
SM and Zhou JY: MicroRNA-206 inhibits the viability and migration
of human lung adenocarcinoma cells partly by targeting MET. Oncol
Lett. 12:1171–1177. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Raghav K, Bailey AM, Loree JM, Kopetz S,
Holla V, Yap TA, Wang F, Chen K, Salgia R and Hong D: Untying the
gordion knot of targeting MET in cancer. Cancer Treat Rev.
66:95–103. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao Y, Tao Q, Li S, Zheng P, Liu J and
Liang X: Both endogenous and exogenous miR-139-5p inhibit
Fusobacterium nucleatum-related colorectal cancer
development. Eur J Pharmacol. 888:1734592020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liao H, Ahmed M, Markezana A, Zeng G,
Stechele M, Galun E and Goldberg SN: Thermal ablation induces
transitory metastatic growth by means of the STAT3/c-Met molecular
pathway in an intrahepatic colorectal cancer mouse model.
Radiology. 294:464–472. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yao JF, Li XJ, Yan LK, He S, Zheng JB,
Wang XR, Zhou PH, Zhang L, Wei GB and Sun XJ: Role of HGF/c-Met in
the treatment of colorectal cancer with liver metastasis. J Biochem
Mol Toxicol. 33:e223162019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu Z, Zhu C, Chen C, Zong Y, Feng H, Liu
D, Feng W, Zhao J and Lu A: CCL19 suppresses angiogenesis through
promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A
pathway in colorectal cancer. Cell Death Dis. 9:9742018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gherardi E, Birchmeier W, Birchmeier C and
Vande Woude G: Targeting MET in cancer: Rationale and progress. Nat
Rev Cancer. 12:89–103. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Viticchiè G and Muller PAJ: c-Met and
other cell surface molecules: Interaction, activation and
functional consequences. Biomedicines. 3:46–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yamaoka T, Kusumoto S, Ando K, Ohba M and
Ohmori T: Receptor tyrosine kinase-targeted cancer therapy. Int J
Mol Sci. 19:34912018. View Article : Google Scholar
|
|
41
|
Organ SL and Tsao MS: An overview of the
c-MET signaling pathway. Ther Adv Med Oncol. 3 (Suppl 1):S7–S19.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Comoglio PM, Trusolino L and Boccaccio C:
Known and novel roles of the MET oncogene in cancer: A coherent
approach to targeted therapy. Nat Rev Cancer. 18:341–358. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lu Z, Song N, Shen B, Xu X, Fang Y, Shi Y,
Ning Y, Hu J, Dai Y, Ding X, et al: Syndecan-1 shedding inhibition
to protect against ischemic acute kidney injury through HGF target
signaling pathway. Transplantation. 102:e331–e344. 2018. View Article : Google Scholar : PubMed/NCBI
|
